Updated Jul 16, 2026
Crowley John J has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
John J. Crowley is the Chief Financial Officer of Centessa Pharmaceuticals plc, a biopharmaceutical company focused on developing innovative medicines. He has extensive experience in financial management and strategy within the pharmaceutical industry.
| Role | Chief Financial Officer |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | CNTA | Centessa Pharmaceuticals plc | D — Derivative transaction | 45.0K | — | |
| 2026-02-04 | CNTA | Centessa Pharmaceuticals plc | A — Grant or award | 45.0K | $0.00 |
John J. Crowley is the Chief Financial Officer of Centessa Pharmaceuticals plc, a biopharmaceutical company focused on developing innovative medicines. He has extensive experience in financial management and strategy within the pharmaceutical industry.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Crowley John J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.